Effect of berberine on nitric oxide production during oxygen-glucose deprivation/reperfusion in OLN-93 oligodendrocytes

Pakistan Journal of Biological Sciences

Volumn 17, Issue 11, 2014, Pages 1185-1189

  Nadjafi, Shabnam ^a   Ebrahimi, Soltan Ahmad ^a   Rahbar Roshandel, Nahid ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Berberine; Nitric oxide; OLN 93 oligodendrocyte; Oxygen glucose deprivation

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; BERBERINE; ENZYME INHIBITOR; GLUCOSE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL HYPOXIA; CELL PROTECTION; DEFICIENCY; DOWN REGULATION; DRUG EFFECTS; METABOLISM; OLIGODENDROGLIA; RAT; TIME; TRANSFORMED CELL LINE;

ANIMALS; BERBERINE; CELL HYPOXIA; CELL LINE, TRANSFORMED; CYTOPROTECTION; DOWN-REGULATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLUCOSE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGODENDROGLIA; OXYGEN; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 84907208719     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2014.1185.1189     Document Type: Article

References (28)

1. Agresti, C, M.E. Meomartini, S. Amadio, E. Ambrosini and C. Volonte et al, 2005. ATP regulates oligodendrocyte progenitor migration, proliferation and differentiation: Involvement of metabotropic P2 receptors. Brain Res. Rev., 48: 157-165.
2. Brown, G.C., 2010. Nitric oxide and neuronal death. Nitric Oxide, 23: 153-165.
3. Chai, Y.S., I. Hu, F. Lei, Y.G. Wang and Z. Y. Yuan et al, Effect of berberine on cell cycle arrest and cell survival during cerebral ischemia and reperfusion and correlations with p53/cyclin Dl and PI3K7Akt. Eur. I. Pharmacol, 708: 44-55.
4. Chai, Y.S., Z.Y. Yuan, F. Lei, Y.G. Wang and I. Hu et al, Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia. PLoS ONE, Vol. 9. 10.1371/journal.pone.0090850
5. Cui, H.S., K. Matsumoto, Y. Murakami, H. Hori and Q. Zhao et al, 2009. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: Involvement of B-cell lymphoma 2 phosphorylation suppression. Biol. Pharm. Bull., 32: 79-85.
6. Frantseva, M.V., P.L. Carlen and H. El-Beheny, 1999. A submersion method to induce hypoxic damage in organotypic hippocampal cultures. I. Neurosci. Methods, 89: 25-31.
7. Giaume, C, F. Kirchhoff, C. Matute, A. Reichenbach and A. Verkhratsky, 2007. Glia: The fulcrum of brain diseases. Cell Death Differ., 14: 1324-1335.
8. Hsu, Y.Y., Y.T. Tseng and Y.C. Lo, 2013. Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. Toxicol. Applied Pharmacol.,272: 787-796.
9. Hu, I., Y. Chai, Y. Wang, M.M. Kheir and H. Uetal, 2012. PI3K p55a promoter activity enhancement is involved in the anti-apoptotic effect of berberine against cerebral ischemia-reperfusion. Eur. I. Pharmacol., 674: 132-142.
10. Karadottir, R., P. Cavelier, L.H. Bergersen and D. Attwell, 2005. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature, 438: 1162-1166.
11. Kaur, C, V. Sivakumar, L.S. Ang and A. Sundaresan, 2006. Hypoxic damage to the periventricular white matter in neonatal brain: Role of vascular endothelial growth factor, nitric oxide and excitotoxicity. I. Neurochem., 98: 1200-1216.
12. Kew, J.N.C. and J.A. Kemp, 2005. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology, 179: 4-29.
13. Knott, A.B. and E. Bossy-Wetzel, 2009. Nitric oxide in health and disease of the nervous system. Antioxidants Redox Signal, 11: 541-554.
14. Matute, C, E. Alberdi, M. Domercq, F. Perez-Cerda and A. Perez-Samartin et al., 2001. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neuroscl, 24: 224-230.
15. Matute, C, 2006. Oligodendrocyte NMDA receptors: A novel therapeutic target. Trends Mol. Med., 12: 289-292.
16. Matute, C, E. Alberdi, M. Domercq, M. V. Sanchez-Gomez and A. Perez-Samartin et al., 2007. Excitotoxic damage to white matter. I. Anatomy, 210: 693-702.
17. Matute, C, 2010. Calcium dyshomeostasis in white matter pathology. Cell Calcium, 47: 150-157.
18. Nadjafi, S., S.A. Ebrahimi and N. Rahbar-Roshandel, 2014. Protective effects of berberine on oxygen-glucose deprivation/reperfusion on oligodendrocyte cell line (OLN-93). Int. I. Prev. Med.
19. Rahbar-Roshandel, N, L. Razavi, B. Tavakoli-Far and M. Mahmoudian, 2008. Mebudipine and dibudipine protect PCI 2 cells against oxygen-glucose deprivation and glutamate-induced cell death. Pathophysiology, 15: 227-231.
20. Richter-Landsberg, C. and M. Heinrich, 1996. OLN-93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. I. Neuroscl Res., 45: 161-173.
21. Salter, M.G. and R. Fern, 2005. NMDA receptors are expressed in developing oligodendrocyte processes andmediate injury. Nature, 438: 1167-1171.
22. Szydlowska, K. and M. Tymianski, 2010. Calcium, ischemia and excitotoxicity. Cell Calcium, 47:122-129.
23. Tavakoli-Far, B., N. Rahbar-Roshandel, P. Rahimi-Moghaddam and M. Mahmoudian, 2009. Neuroprotective effects of mebudipine and dibudipine on cerebral oxygen-glucose deprivation/reperfusion injury. Eur. I. Pharmacol, 610: 12-17.
24. Wang, X, R. Wang, D. Xing, H. Su and C. Ma et al, 2005. Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci., 77: 3058-3067.
25. Wang, Y. and Z.H. Qin, 2010. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis, 15: 1382-1402.
26. Wilkins, A., H. Majed, R. Layfield, A. Compston and S. Chandran, 2003. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: A novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. I. Neuroscl, 23: 4967-4974.
27. Yao, S., P. Pandey, A. Ljunggren-Rose and S. Sriram, 2010. LPS mediated injury to oligodendrocytes is mediated by the activation of nNOS: Relevance to human demyelinating disease. Nitric Oxide, 22: 197-204.
28. Zhang, Q., Z. Qian, L. Pan, H. Li and H. Zhu, 2012. Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia. Acta Physiologica Hungarica, 99: 311-323.